Company insight
Optimise lab workflows with the right assay kits
Valerie Erlewein, a medical technologist at Klinikum Ludwigshafen, Germany, and a professional working in a molecular laboratory at the hospital clinic, discusses their experiences using GenomEra®
Assay Kits from Uniogen. I
n the dynamic landscape of healthcare, the need for high-quality and efficient diagnostic tools has never been more pronounced. Healthcare professionals continuously strive to find solutions that can not only increase the accuracy of diagnoses but also streamline laboratory workflows. Here’s how Uniogen’s GenomEra®
CDX System
and rapid GenomEra PCR Assay Kits are proving to be an invaluable asset in their laboratory operations.
A day in the life in a molecular laboratory Working in a PCR laboratory in a large hospital entails dealing with a variety of pathogens and conducting numerous tests to ensure timely and accurate results. The laboratory focuses its efforts on dealing with pathogens that are currently common, and the selection of tests is heavily influenced by the number of samples they receive for a particular pathogen.
GenomEra Assay Kits have proved to be a robust tool for healthcare professionals.
are critical features that denote a good test. Adding to their appeal is their ease of handling, making them accessible to everyone, including those with no prior experience with PCR. Moreover, Erlewein thinks, one of the standout features of GenomEra CDX System is the capability to test four samples
“As Uniogen continues to adapt and innovate, we look forward to seeing how they will further revolutionise laboratory workfl ows, fostering a more effi cient and responsive healthcare system.”
“This not only makes the testing process worthwhile but also provides an avenue for the laboratory to generate revenue,” says Valerie Erlewein, a medical technologist at Klinikum Ludwigshafen.
The GenomEra advantage In this laboratory, the professionals have found a reliable partner in GenomEra Assay Kits, specifically utilising the GenomEra SARS-CoV-2, FluA/B + RSV Assay Kit. Erlewein gave a hearty endorsement for these tests, pointing out their high sensitivity and specificity that
Practical Patient Care /
www.practical-patient-care.com
in a single run – a functionality that sets it apart from devices from other companies.
A pillar of support
When selecting a new test, smooth customer service is vital for the clinic in which Erlewein is working. It ensures the laboratory professionals know about updates and new information regarding the tests. This has been a particularly positive experience with the Uniogen team, both with the German distributor and with Uniogen’s customer support in Finland, where assistance has been swift
and effective, helping to resolve issues and facilitate smoother operations.
Moving forward with GenomEra As for usability, the system has proved very user-friendly, enabling even colleagues without any experience with PCR to use it. GenomEra Assay Kits have proved to be a robust tool in the arsenal of healthcare professionals, merging high sensitivity and specificity with ease of use. “As Uniogen continues to adapt and innovate, we look forward to seeing how they will further revolutionise laboratory workflows, fostering a more efficient and responsive healthcare system,” Erlewein says. “My warmest thank you to the Uniogen’s team for their continued support and commitment to excellence,” she adds. ● The GenomEra CDX System is CE marked according to the regulation (EU) 2017/746 (IVDR). The GenomEra SARS-CoV-2, Flu A/B + RSV Assay Kit has received the European CE marking for In Vitro Diagnostic (IVD) medical devices according to the requirements of EU Directive 98/79/EC (IVDD) and is available in European markets. Elsewhere, please contact your local distributor for availability. The product is manufactured by Uniogen, Finland.
https://uniogen.com 15
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61
